摘要
近年来,在医改及税务的变化之下,导致医药企业的竞争越来越激烈,使得医药企业面临更加严峻的挑战。基于此,论文概述了内部控制视角下增强医药企业财务管理与风险防范的意义,分别分析了内部控制、财务管理在风险防范中遇到的困境,探讨了增强医药企业内部控制与财务管理在风险防范中的作用,仅供同行参考和借鉴。
In recent years,under the changes of medical reform and tax,the competition among pharmaceutical enterprises is becoming more and more fierce,which makes pharmaceutical enterprises face more severe challenges.Based on this,the paper outlines the significance of strengthening the financial management and risk prevention of pharmaceutical enterprises from the perspective of internal control,and analyzes the difficulties encountered by internal control and financial management in risk prevention,discusses the role of strengthening internal control and financial management in risk prevention of pharmaceutical enterprises,which is only for peer reference.
作者
宋君
SONG Jun(Jinan Hanci Biotechnology Co.,Ltd.,Jinan 250200,China)
出处
《中小企业管理与科技》
2021年第20期137-138,共2页
Management & Technology of SME
关键词
医药企业
内部控制
财务管理
风险防范
pharmaceutical enterprise
internal control
financial management
risk prevention